Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Using a smartphone app to help lung cancer patients stick to their rehabilitation exercises after surgery

Official title: A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients

Run by Zhongshan People's Hospital, Guangdong, China · NCT05990946 · Data updated 2026-11-12

This study is testing whether a smartphone app can help lung cancer patients stick to their rehabilitation exercises after surgery by allowing them to report their symptoms and get feedback from their doctors.

More Postoperative Complications trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment736 (estimated)
SponsorZhongshan People's Hospital, Guangdong, China
Academic / other
Locations1 site (Zhongshan, Guangdong)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedMarch 30, 2027
Study endsJune 30, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT05990946 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-75 undergoing minimally invasive lung cancer resection who can use smartphones.

Probably not a fit

Patients who have significant comorbidities, previous lung surgeries, or physical limitations that prevent exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates the effectiveness of a smartphone app that enables remote symptom monitoring and management for patients recovering from video-assisted thoracic surgery (VATS) for lung cancer. Patients will be randomized into two groups: one receiving electronic patient-reported outcomes (ePRO) with clinician feedback and the other receiving ePRO without feedback. The primary focus is on improving adherence to prescribed pulmonary rehabilitation exercises during the month following discharge. Secondary outcomes include monitoring postoperative complications, hospital readmissions, and patient satisfaction. If successful, this approach could be expanded to benefit a larger population of postoperative patients.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance recovery and adherence to rehabilitation exercises for lung cancer patients post-surgery.

How similar studies have gone: Other studies have shown promise in using technology for remote monitoring and rehabilitation, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-75 years old
* preoperative clinical diagnosis or suspicion of resectable primary lung cancer
* Able to use smartphones and complete electronic questionnaires
* Signed informed consent

Exclusion Criteria:

* conversions to open thoracotomy during surgery
* ECOG score \> 1
* Received neoadjuvant therapy
* Previous lung resection surgery
* Unable to exercise due to physical limitations
* Continuous systemic corticosteroid use within 1 month before enrollment
* Unresolved toxicity above Grade 1 from previous treatments
* Significant comorbidities or medical history

Where it's running

  • No.2 Sunwen East Rd.
    Zhongshan, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.